Caladrius Biosciences, Inc. (LSTA) Misses Q3 EPS by 638c

Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q3 EPS of ($7.88), $6.38 worse than the analyst estimate of ($1.50).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Benchmark Reiterates Buy Rating on Malibu Boats (MBUU) on Significant Earnings Upside
• BofA sees mixed signals for European software from US SaaS